Balance Sheet Data
Esperion Therapeutics, Inc. (ESPR)
$1.44
+0.11 (+8.27%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 36.97 | 166.13 | 304.96 | 208.89 | 124.78 | 95.96 | 87.44 | 79.67 | 72.60 | 66.15 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | - | 22.93 | 33.73 | 25.42 | 23.16 | 21.11 | 19.23 | 17.52 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | 16.14 | 34.39 | 35.20 | 22.37 | 20.38 | 18.57 | 16.92 | 15.42 |
| Inventories (%) | ||||||||||
| Accounts Payable | 44.89 | 28.86 | 51.98 | 17.56 | 23.04 | 16.44 | 14.98 | 13.65 | 12.44 | 11.33 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.15 | -0.95 | -13.37 | -1.73 | -1.66 | -1.51 | -1.38 | -1.26 | -1.14 | -1.04 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.